WGS
GeneDx Holdings Corp

4,461
Mkt Cap
$3.86B
Volume
159.00
52W High
$147.71
52W Low
$55.17
PE Ratio
2,216.09
WGS Fundamentals
Price
$135.01
Prev Close
$126.92
Open
$127.67
50D MA
$126.24
Beta
1.59
Avg. Volume
585,581.00
EPS (Annual)
-$1.94
P/B
13.21
Rev/Employee
$305,450.00
Loading...
Loading...
News
all
press releases
GeneDx Holdings Corp. (NASDAQ:WGS) Receives Consensus Rating of "Moderate Buy" from Brokerages
GeneDx Holdings Corp. (NASDAQ:WGS - Get Free Report) has earned an average rating of "Moderate Buy" from the eleven brokerages that are covering the stock, Marketbeat.com reports. One equities...
MarketBeat·7h ago
News Placeholder
More News
News Placeholder
GeneDx Holdings Corp. $WGS Shares Sold by Calamos Advisors LLC
Calamos Advisors LLC reduced its holdings in GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) by 22.3% during the 2nd quarter, according to the company in its most recent filing with the Securities...
MarketBeat·5d ago
News Placeholder
Thompson Davis & CO. Inc. Purchases 5,180 Shares of GeneDx Holdings Corp. $WGS
Thompson Davis & CO. Inc. lifted its holdings in GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) by 36.6% during the 2nd quarter, according to its most recent filing with the Securities & Exchange...
MarketBeat·6d ago
News Placeholder
Simplify Asset Management Inc. Invests $5.23 Million in GeneDx Holdings Corp. $WGS
Simplify Asset Management Inc. bought a new position in shares of GeneDx Holdings Corp. (NASDAQ:WGS - Free Report) during the 2nd quarter, according to its most recent 13F filing with the SEC. The...
MarketBeat·8d ago
News Placeholder
GeneDx (NASDAQ:WGS) Reaches New 52-Week High - Here's What Happened
GeneDx (NASDAQ:WGS) Sets New 1-Year High - Here's What Happened...
MarketBeat·9d ago
News Placeholder
GeneDx to Showcase Advancements in Gene-Disease Discovery, Long-Read Sequencing and More at National Society of Genetic Counselors (NSGC) 2025 Annual Meeting
GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced it will unveil research findings during four key sessions at the 2025 National Society...
Business Wire·14d ago
News Placeholder
GeneDx to Participate in Upcoming Investor Conferences
GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences: Stifel 2025...
Business Wire·16d ago
News Placeholder
GeneDx Holdings Corp. (WGS) Q3 Earnings and Revenues Surpass Estimates
GENEDX HOLDINGS (WGS) delivered earnings and revenue surprises of +75.00% and +12.47%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·23d ago
News Placeholder
GeneDx Reports Third Quarter 2025 Financial Results and Business Highlights
GeneDx Holdings Corp. (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today reported its financial results for the third quarter of 2025. GeneDxs accelerated...
Business Wire·23d ago
News Placeholder
GeneDx Holdings Corp. (NASDAQ: WGS) Investor Reminder: Schubert Jonckheer Investigating Possible False Claims
GeneDx Holdings Corp. (NASDAQ: WGS) Investor Reminder: Schubert Jonckheer Investigating Possible False Claims GeneDx Holdings Corp. (NASDAQ: WGS) Investor Reminder: Schubert Jonckheer Investigating...
PR Newswire·24d ago

Latest WGS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.